Imaging the primate adrenal medulla with [123I] and [131I] meta-iodobenzylguanidine: concise communication.
Imaging the primate adrenal medulla with [123I] and [131I] meta-iodobenzylguanidine: concise communication.
复制标题
使用 [123I] 和 [131I] 间碘苄胍对灵长类动物肾上腺髓质进行成像:简洁的交流。
DOI:
10.1016/s0300-595x(80)80035-1
复制
发表时间:
1981
期刊:
影响因子:
--
通讯作者:
W. Beierwaltes
中科院分区:
文献类型:
--
作者:
D. Wieland;L. E. Brown;M. Tobes;W. Rogers;D. D. Marsh;T. Mangner;D. Swanson;W. Beierwaltes
An evaluation of radioiodinated meta-iodobenzylguanidine (m-IBG) as an adrenomedullary imaging agent is reported in 15 rhesus monkeys. Scintiscans of the monkey adrenal medulla have been obtained with [123I]- and [m-131I]IBG at 2-6 days after injection. The imaging superiority of m-IBG over its positional isomer, para-iodobenzylguanidine (p-IBG), is documented in both dogs and monkeys. Administration of reserpine, a depletor of catecholamine stores, markedly lowers the [m-131I]-IBG content of the dog adrenal medulla, but the adrenergic blocking agents phenoxybenzamine and propranolol have no effect. Subcellular fractionation of the dog's adrenal medullae reveals that m-IBG is sequestered mainly in the chromaffin storage granules. The results of this study suggest that radioiodinated m-IBG, previously reported to image the primate myocardium, also merits evaluation as a clinical radiopharmaceutical for the adrenal medulla.